CClinicalTrials.gg
CompletedNCT06426927PeLear CCCUpdated Jan 21, 2026Results posted

PeLear CCC: Proyecto Latino Contra Cancer Colorrectal

An interventional study of Colorectal Cancer Educational Videos in Spanish in Colorectal Cancer, Rectal Cancer and Colon Cancer, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The study aims to recruit 60 Spanish speaking individuals who identify as Latinos, are 18 years or older and attend the Saint Thomas More (STM) Church in Chapel Hill. Study participants will be asked to attend an educational session at STM Church during which their baseline knowledge on colorectal cancer (CRC) and willingness to participate in cancer clinical trials (CCT) will be assessed through a questionnaire in Spanish. Following this, participants will watch three educational videos on CRC in Spanish. After watching the videos, CRC knowledge and willingness to participate in CCTs will be reassessed. Thirty +/- 7 days after participation in the educational session, participants will be invited back at STM Church in order to complete a follow-up questionnaire assessing CRC knowledge, willingness to participate in CCTs and perceived barriers preventing Latinos from participating in CCTs. Twenty of the 60 recruited participants will be asked to participate in a qualitative one-on-one interview aimed at identifying barriers preventing Latinos from participating in CCTs.

It should be noted that cancer is the leading cause of death in the United States (US) Latino community, with CRC accounting for 10% of this overall mortality. Despite this, Latinos suffer from disparities in access to care, cancer screening, treatment, and representation in CCTs. In fact, although Latino individuals are among the largest and fastest growing communities of color in the US, currently comprising 18.7%, their representation in CCTs remains low. This is of concern because: 1) advances arising from trials with limited Latino representation may not be applicable to the Latino population, and 2) decreased Latino participation in CCTs may delay Latino access to novel therapies in a timely fashion. The investigators conducting this study believe that low cancer-specific health knowledge may be impacting Latino representation and willingness to participate in CCTs and can be addressed through culturally and linguistically appropriate community-based educational interventions. Latino CCT underrepresentation is a multifaceted phenomenon and bidirectional barriers at the physician-, healthcare system-, and patient-level are significant contributors. Therefore, understanding the multiple driving forces and barriers is essential to identifying potential targets for improvement.

Read the detailed description

This pilot project aims to address the Clinical and Translational Science (CTS) roadblock of underrepresentation of Latinos in cancer clinical trials (CCTs) through a community-based, culturally, and linguistically appropriate educational intervention aimed at increasing health knowledge on a specific cancer. Colorectal cancer (CRC) will be the "use case" and the church will be the venue for Latino recruitment. This project will lead to the identification of novel Latino-perceived barriers to CCT enrollment, which will be applicable in other fields of medicine aiming to increase Latino CCT enrollment. The investigators believe that one barrier to recruitment for CCTs is low health education, specifically regarding cancers affecting the community, such as CRC, a commonly diagnosed cancer in the US Latino population. Therefore, the hypothesis that an increase in health knowledge in Latinos on a specific cancer mediates a change in their willingness to participate in CCTs will be tested. To do this, three educational CRC videos in Spanish will be created. The first video will review CRC symptoms, the second video will review CRC risk factors while the third video will provide information on CRC facts, screening, treatment and CCTs. In addition, a translated, non-validated questionnaire based on 3 sub-scales from 2 CRC knowledge questionnaires previously validated in English will be developed and pilot tested. Therefore, the Specific Aims of this Pilot Project are to:

  1. Identify novel Latino-perceived barriers to participation in CCTs.
  2. Assess the association between an educational video and CRC knowledge.
  3. Assess the potential relationship between an increase in health knowledge of a specific cancer via an educational video in Spanish and willingness to participate in CCTs.

To achieve these aims, recruit 60 Latino, Spanish speaking attendees of the Saint Thomas More (STM) Church in Chapel Hill will be recruited. The study will consist of three Study Days:

  1. Study Day 1: Enrolled participants will be asked to attend an educational session at STM Church. During the educational session their baseline knowledge on CRC and their baseline willingness to participate in CCTs will be assessed through a questionnaire in Spanish. Following this, participants will watch three educational CRC videos in Spanish and then their CRC knowledge as well as their willingness to participate in CCTs will be reassessed.
  2. Study Day 2: Thirty +/- 7 days after the educational session, participants will be asked to return to STM Church in order to complete a follow-up questionnaire in Spanish. The questionnaire will assess their level of retainment of CRC knowledge, their willingness to participate in CCTs as well as assess in an open-ended fashion their perceived barriers to CCT participation.
  3. Study Day 3: Twenty of the 60 enrolled participants will be asked to participate in a qualitative one-on-one interview aimed at identifying Latino perceived barriers to CCT participation.
02

Conditions studied

  • Colorectal Cancer
  • Rectal Cancer
  • Colon Cancer
  • Colon Rectal Cancer
  • Rectal Neoplasms
  • Colon Adenocarcinoma
  • Hereditary Nonpolyposis Colon Cancer

Keywords

  • Colorectal Cancer
  • Latino
  • Barriers
  • Cancer Clinical Trials
  • Spanish
  • Familial Colorectal Cancer
  • Lynch Syndrome
  • Hispanic
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 60 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Spanish speaking
  • Identifying as Latino
  • 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Non-Spanish speakers
  • Not identifying as Latino
  • Younger than 18 years old
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Educational Videos

    Enrolled participants will watch three educational videos in Spanish pertaining to: (1) Colorectal Cancer (CRC) symptoms; (2) CRC risk factors and (3) CRC facts, screening, treatment, and Cancer Clinical Trials (CCT).

    Other: Colorectal Cancer Educational Videos in Spanish

Interventions

  • OtherColorectal Cancer Educational Videos in Spanish

    Enrolled participants will watch three educational videos on Colorectal Cancer (CRC) in Spanish. Knowledge on CRC symptoms, risk factors, facts, screening and treatment will be assessed before and immediately after the educational video and at 30 +/- 7 days. In addition, the association between increase in CRC knowledge and willingness to participate in Cancer Clinical Trials (CCT) will be explored.

06

What researchers measure

Primary outcomes

  1. Attitudes Regarding Participation in Clinical Trials-Conceptual Themes (General Clinical Trials)

    Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 2 conceptual themes for attitudes regarding general clinical trials will be reported in terms of percentage of participants.

    Time frame: 30 days after participation in Study Day 2

  2. Attitudes Regarding Participation in Cancer Clinical Trials-Conceptual Themes (Cancer Clinical Trials)

    Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 2 conceptual themes for attitudes regarding cancer clinical trials will be reported in terms of percentage of participants.

    Time frame: 30 days after participation in Study Day 2

  3. Perceptions of Latino Community for Increasing Enrollment in Randomized Clinical Trials-Conceptual Themes (General Clinical Trials)

    Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 2 conceptual themes for perceptions of the Hispanic/Latino community will be reported in terms of percentage of participants.

    Time frame: 30 days after participation in Study Day 2

  4. Holistic Themes

    Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 3 holistic themes will be reported in terms of percentage of participants.

    Time frame: 30 days after participation in Study Day 2

Secondary outcomes

  1. Association of Educational Videos on Knowledge of Colorectal Cancer Symptoms

    Use of appropriate statistical measures to compare total number of correct responses across three time points (at baseline, post-video and 30+/- 7 days follow-up) accounting for multiple observations within subjects. Knowledge pertaining to Colorectal Cancer (CRC) symptoms will be assessed using the "Knowledge of Warning Signs" questions from the "Bowel Cancer Awareness Measure". Potential answers include "Yes", "No" and "Don't Know". The overall score will range from 0 to 9 and it is anticipated that average scores will increase after the intervention. Higher scores imply greater knowledge of symptoms.

    Time frame: On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes); Study Day 2: 30 +/- 7 days

  2. Association of Educational Videos on Knowledge of Colorectal Cancer Risk Factors

    Use of appropriate statistical measures to compare mean of correct responses across three time points (at baseline, post-video and 30+/- 7 days follow-up) accounting for multiple observations within subjects. Knowledge pertaining to Colorectal Cancer (CRC) risk factors will be assessed using the "Knowledge of Risk Factors" questions from the "Bowel Cancer Awareness Measure". This scale is measured using a Likert 1-5 scale with "1" corresponding to "Strongly Disagree" and "5" corresponding to "Strongly Agree". The overall score will range from 1 to 5 and it is anticipated that the average scores will increase after the intervention. Higher scores imply greater knowledge of risk factors.

    Time frame: On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes); Study Day 2: 30 +/- 7 days

  3. Association of Educational Videos on Knowledge of Colorectal Cancer Screening and Facts

    Use of appropriate statistical measures to compare mean of correct responses across three time points (at baseline, post-video and 30+/- 7 days follow-up) accounting for multiple observations within subjects. Knowledge of Colorectal Cancer (CRC) screening and general facts will be assessed using nine questions from the "Colorectal Cancer Screening Decision Quality Instrument (CRC-DQI)". The overall score will range from 0 to 9 and it is anticipated that average scores will increase after the intervention. Higher scores imply greater knowledge of colorectal cancer screening and facts.

    Time frame: On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes); Study Day 2: 30 +/- 7 days

  4. Association of Watching the Video and Willingness to Participate in Cancer Clinical Trials

    Appropriate statistical measures on the paired responses of participants will be used to test the association between watching the video and willingness to participate in CCTs. The mediating effect of Study Day 1 post-video health knowledge levels (M) on the relationship between educational video (X) and willingness to participate in CCTs (Y) will be explored. In a structural equation model with a series of mixed-effects generalized linear models, Y will be predicted by both X and M, combining the estimated relationship of M and Y. The mediated indirect effect (from X to Y, through M) will then be estimated and tested using the bootstrapping method with 1,000 replications, and the proportion of the effect being mediated will be reported as the effect size. The number of participants who responded "Yes" to willingness to participate in cancer clinical trials are reported in the data table.

    Time frame: On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes) after the video projection

07

Results

Posted Jan 14, 2026

Participant flow

Participant flow — Overall Study
MilestoneEducational Videos
Started60
Completed60
Not completed0

Outcome measures

PrimaryAttitudes Regarding Participation in Clinical Trials-Conceptual Themes (General Clinical Trials)

Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 2 conceptual themes for attitudes regarding general clinical trials will be reported in terms of percentage of participants.

Time frame:
30 days after participation in Study Day 2
Reported as:
Number · percentage of participants
Attitudes Regarding Participation in Clinical Trials-Conceptual Themes (General Clinical Trials)
percentage of participantsEducational Videos
Work is a priority85
Preference for communicating in Spanish80
PrimaryAttitudes Regarding Participation in Cancer Clinical Trials-Conceptual Themes (Cancer Clinical Trials)

Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 2 conceptual themes for attitudes regarding cancer clinical trials will be reported in terms of percentage of participants.

Time frame:
30 days after participation in Study Day 2
Reported as:
Number · percentage of participants
Attitudes Regarding Participation in Cancer Clinical Trials-Conceptual Themes (Cancer Clinical Trials)
percentage of participantsEducational Videos
Fear of side effects60
Knowledge is "peace of mind"45
PrimaryPerceptions of Latino Community for Increasing Enrollment in Randomized Clinical Trials-Conceptual Themes (General Clinical Trials)

Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 2 conceptual themes for perceptions of the Hispanic/Latino community will be reported in terms of percentage of participants.

Time frame:
30 days after participation in Study Day 2
Reported as:
Number · percentage of participants
Perceptions of Latino Community for Increasing Enrollment in Randomized Clinical Trials-Conceptual Themes (General Clinical Trials)
percentage of participantsEducational Videos
Go to where Latinos congregate90
Video-based communication is preferred80
PrimaryHolistic Themes

Twenty participants were invited for qualitative interviews. Qualitative, semi-structured, one-on-one interviews will be performed in Spanish. The interviews will be recorded and transcribed. The ATLAS.ti software will be used for the transcript analysis. The top 3 holistic themes will be reported in terms of percentage of participants.

Time frame:
30 days after participation in Study Day 2
Reported as:
Number · percentage of participants
Holistic Themes
percentage of participantsEducational Videos
Perception of Clinical Trials (CTs): "Positives Outweigh the Negatives"58
Attitudes regarding CTs: "Factors Alleviating/ Exacerbating Fear Influence Attitude"100
Attitudes regarding Cancer CTs: "Peace of Mind vs. Bodily Invasion/Side Effects Influence Attitude"45
SecondaryAssociation of Educational Videos on Knowledge of Colorectal Cancer Symptoms

Use of appropriate statistical measures to compare total number of correct responses across three time points (at baseline, post-video and 30+/- 7 days follow-up) accounting for multiple observations within subjects. Knowledge pertaining to Colorectal Cancer (CRC) symptoms will be assessed using the "Knowledge of Warning Signs" questions from the "Bowel Cancer Awareness Measure". Potential answers include "Yes", "No" and "Don't Know". The overall score will range from 0 to 9 and it is anticipated that average scores will increase after the intervention. Higher scores imply greater knowledge of symptoms.

Time frame:
On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes); Study Day 2: 30 +/- 7 days
Reported as:
Mean · score on a scale
Association of Educational Videos on Knowledge of Colorectal Cancer Symptoms
score on a scaleEducational Videos
Study Day 1: Baseline4.10 ± 0.36
Study Day 1: Post-video7.23 ± 0.32
Study Day 2: 30 +/- 7 days6.95 ± 0.29
Statistical analysis
  • Educational Videos · ANOVA · p = <0.0001
  • Educational Videos · ANOVA · p = <0.0001
SecondaryAssociation of Educational Videos on Knowledge of Colorectal Cancer Risk Factors

Use of appropriate statistical measures to compare mean of correct responses across three time points (at baseline, post-video and 30+/- 7 days follow-up) accounting for multiple observations within subjects. Knowledge pertaining to Colorectal Cancer (CRC) risk factors will be assessed using the "Knowledge of Risk Factors" questions from the "Bowel Cancer Awareness Measure". This scale is measured using a Likert 1-5 scale with "1" corresponding to "Strongly Disagree" and "5" corresponding to "Strongly Agree". The overall score will range from 1 to 5 and it is anticipated that the average scores will increase after the intervention. Higher scores imply greater knowledge of risk factors.

Time frame:
On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes); Study Day 2: 30 +/- 7 days
Reported as:
Mean · score on a scale
Association of Educational Videos on Knowledge of Colorectal Cancer Risk Factors
score on a scaleEducational Videos
Study Day 1: Baseline3.06 ± 0.08
Study Day 1: Post-video4.08 ± 0.15
Study Day 2: 30 +/- 7 days3.93 ± 0.12
Statistical analysis
  • Educational Videos · ANOVA · p = <0.0001
  • Educational Videos · ANOVA · p = <0.0001
SecondaryAssociation of Educational Videos on Knowledge of Colorectal Cancer Screening and Facts

Use of appropriate statistical measures to compare mean of correct responses across three time points (at baseline, post-video and 30+/- 7 days follow-up) accounting for multiple observations within subjects. Knowledge of Colorectal Cancer (CRC) screening and general facts will be assessed using nine questions from the "Colorectal Cancer Screening Decision Quality Instrument (CRC-DQI)". The overall score will range from 0 to 9 and it is anticipated that average scores will increase after the intervention. Higher scores imply greater knowledge of colorectal cancer screening and facts.

Time frame:
On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes); Study Day 2: 30 +/- 7 days
Reported as:
Mean · score on a scale
Association of Educational Videos on Knowledge of Colorectal Cancer Screening and Facts
score on a scaleEducational Videos
Study Day 1: Baseline3.80 ± 0.20
Study Day 1: Post-video6.05 ± 0.20
Study Day 2: 30 +/- 7 days5.12 ± 0.22
Statistical analysis
  • Educational Videos · ANOVA · p = <0.0001
  • Educational Videos · ANOVA · p = <0.0001
SecondaryAssociation of Watching the Video and Willingness to Participate in Cancer Clinical Trials

Appropriate statistical measures on the paired responses of participants will be used to test the association between watching the video and willingness to participate in CCTs. The mediating effect of Study Day 1 post-video health knowledge levels (M) on the relationship between educational video (X) and willingness to participate in CCTs (Y) will be explored. In a structural equation model with a series of mixed-effects generalized linear models, Y will be predicted by both X and M, combining the estimated relationship of M and Y. The mediated indirect effect (from X to Y, through M) will then be estimated and tested using the bootstrapping method with 1,000 replications, and the proportion of the effect being mediated will be reported as the effect size. The number of participants who responded "Yes" to willingness to participate in cancer clinical trials are reported in the data table.

Time frame:
On Study Day 1: Immediately before (baseline) and immediately post-video (within 30 minutes) after the video projection
Reported as:
Count of participants · Participants
Association of Watching the Video and Willingness to Participate in Cancer Clinical Trials
ParticipantsEducational Videos
Study Day 1: Baseline55
Study Day 1: Post-video54
Statistical analysis
  • Educational Videos · Mixed Models Analysis · p = 0.56 · Average causal mediated effect (acme): 0.01

Adverse events

Collected over Adverse Events were monitored from the time of signing informed consent through study completion, up to 30 days for participants involved in the educational video only and up to 60 days for those who participated in the qualitative interviews.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Educational Videos——0/60 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Educational Videos
Mean51.3 (20 to 73)
Sex: Female, Male
Sex: Female, Male(Participants)Educational Videos
Female31
Male29
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Educational Videos
Hispanic or Latino60
Not Hispanic or Latino0
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Educational Videos
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American0
White25
More than one race1
Unknown or Not Reported34
Region of Enrollment
Region of Enrollment(Participants)Educational Videos
United States60
08

Study locations

1 site
  • Saint Thomas More Church
    Chapel Hill, North Carolina 27514, United States
09

References and documents

Publications

  • Sepucha KR, Feibelmann S, Cosenza C, Levin CA, Pignone M. Development and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions. BMC Med Inform Decis Mak. 2014 Aug 20;14:72. doi: 10.1186/1472-6947-14-72. PubMed 25138444 ↗
  • American Cancer Society. Cancer Facts & Figures for Hispanic/Latino People 2021-2023. Atlanta: American Cancer Society, Inc. 2021.
  • Power E, Simon A, Juszczyk D, Hiom S, Wardle J. Assessing awareness of colorectal cancer symptoms: measure development and results from a population survey in the UK. BMC Cancer. 2011 Aug 23;11:366. doi: 10.1186/1471-2407-11-366. PubMed 21859500 ↗

Study documents

  • Protocol and statistical analysis plan · Nov 21, 2024
  • Informed consent form · Oct 9, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06426927
Lead sponsor
University of North Carolina, Chapel Hill
Collaborators
North Carolina Translational and Clinical Sciences Institute
Responsible party
Sponsor
First posted
May 23, 2024
Start date
Oct 27, 2024
Primary completion
Mar 25, 2025
Completion
Mar 25, 2025
Results posted
Jan 14, 2026
Last update
Jan 21, 2026

Study contacts

José G. Guillem, MD, MPH, MBA
principal investigator · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion